Nuzenio

Ligand Adds More

Ligand Adds More news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 5 latest news signals 3 publisher sources 100/100 entity strength

Latest news

Ligand Pharmaceuticals 2Q 2026: Revenue $63.69M, EPS $2.22— 10-Q Summary - TradingViewTradingView · Fri, 07 Aug 2026 20:11:01 GMTLigand Pharmaceuticals Q2 Earnings Call Highlights - TradingViewTradingView · Thu, 06 Aug 2026 21:03:55 GMTLigand Reports Second Quarter 2026 Financial Results - manilatimes.netmanilatimes.net · Thu, 06 Aug 2026 11:19:22 GMTLigand reports Q2 2026: Revenue $63.7M, Royalties $48.0M, GAAP EPS $2.22, Adjusted EPS $2.37 - TradingViewTradingView · Thu, 06 Aug 2026 11:13:01 GMTLigand Adds More Than 120 Royalty Assets in XOMA Acquisition - Stock TitanStock Titan · Thu, 06 Aug 2026 11:08:47 GMT

Timeline

Fri, 07 Aug 2026 20:11:01 GMTLigand Pharmaceuticals 2Q 2026: Revenue $63.69M, EPS $2.22— 10-Q Summary - TradingView
Thu, 06 Aug 2026 21:03:55 GMTLigand Pharmaceuticals Q2 Earnings Call Highlights - TradingView
Thu, 06 Aug 2026 11:19:22 GMTLigand Reports Second Quarter 2026 Financial Results - manilatimes.net
Thu, 06 Aug 2026 11:13:01 GMTLigand reports Q2 2026: Revenue $63.7M, Royalties $48.0M, GAAP EPS $2.22, Adjusted EPS $2.37 - TradingView
Thu, 06 Aug 2026 11:08:47 GMTLigand Adds More Than 120 Royalty Assets in XOMA Acquisition - Stock Titan

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Ligand Adds More.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

3 distinct publisher/source names are currently connected to this entity page.